Navigation Links
LMS CALM Shoulder Screen(TM) selected by New Jersey physician group to minimize obstetrical risks
Date:5/15/2008

MONTREAL, May 15 /PRNewswire-FirstCall/ - LMS Medical Systems (TSX:LMZ), a healthcare technology company and developer of the CALM(R) patient safety software systems for obstetrics, today announced that it has entered into an agreement with Regional Women's Health Management, LLC (Regional) of New Jersey to license CALM Shoulder Screen. Regional is one of the largest groups of Obstetricians and Gynecologists in New Jersey, serving over 200,000 women annually and delivering over 5000 babies.

CALM Shoulder Screen will assist obstetricians with managing the risks associated with shoulder dystocia (ShD). ShD occurs when a baby's shoulder gets stuck behind the mother's pubic bone during childbirth. It is one of the most feared conditions that can occur during labor and delivery. Potential injuries include injury to the nerves of the baby's arm and shoulder, brain damage and sometimes death.

"Acquiring CALM Shoulder Screen for the benefit of our patients was an obvious choice" commented Frank Caso, President and CEO of Regional, whose group selected and licensed the program from LMS. "We are also very pleased that our carrier has recognized the value of this risk management initiative."

"Shoulder dystocia is one of the scariest crises to occur in obstetrics. Applying ShD maneuvers together with guidelines from the American College of Obstetricians and Gynecologists (ACOG) are simply not enough" commented Dr. Kay, FACOG and Chairman of Regional. "We believe the CALM Shoulder Screen will not only help us to identify the higher risk mothers and take action to avoid a significant number of persistent injuries, but also help us to properly identify those lower risk mothers who have a chance of delivering without unnecessary intervention."

"Injury related to shoulder dystocia has long been thought to be unpredictable and unpreventable to the OBGYN community," commented Diane Cote, CEO of LMS. "The initiative taken by groups such as Regional is
'/>"/>

SOURCE LMS MEDICAL SYSTEMS INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. New treatment effective for patients with shoulder pain
2. A New Study Links High Volume Pain Pumps with the Devastating and Painful Loss of Cartilage Following Arthroscopic Shoulder Surgery
3. How pitching changes little leaguers shoulders
4. Study Author Urges Peers to Stop Using Pain Pumps in the Shoulder Joint as Seasonal Surge in Use Approaches
5. Saline Wash May Ease Shoulder Tendonitis
6. Are People Asking Their Doctors?: Halo Rejuvenator a Holistic Remedy for Headache, Neck and Shoulder Pain
7. Smith & Nephew Endoscopys BIORAPTOR(TM) 2.3 PK Suture Anchor Provides Secure Repair for Shoulder, Hip Instability
8. Comeback to a Pre-Injury Level After Elbow or Shoulder Surgery Disappointing for Pro Baseball Players
9. Controversial shoulder surgery for first-time dislocation proven effective long-term
10. Elbow, Shoulder Injuries Take Heavy Toll on Pro Baseball Players
11. First-Time Shoulder Dislocations Helped by Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... day lead to a novel technique to combat cancer, s...hDay News) -- Belgian researchers have discovered ...sugar for food, and this might lead to new treatme...ive and proliferate, all cells in the body need to...ucose], a process that requires oxygen. Compared w...
(Date:11/21/2008)..., Nov. 21 New research ... a smokeless, spitless tobacco product aimed at yo...e found that RJ Reynolds, Camel Snus - touted as a...ntains surprisingly high levels of nicotine. , ... other snuff products," said Bruce Adkins of the s...
(Date:11/21/2008)...s Intend To Vigorously Protect Investment And Rest...21 Dr. Stephen Joffe, C...nt to their Schedule 13D with the U.S. Securities ...ed a 13D disclosing ownership of 11.4% of LCA-Visi...kPlus fixed-site laser vision correction centers i...
(Date:11/21/2008)... The general membership of the Med...ee new individuals at their Annual,Awards Dinner ...n New York. A,Lifetime Achievement Award will als...edical Advertising Hall of Fame are: , Ronald P...account position,at Sudler & Hennessey. In 19...
Breaking Medicine News(10 mins):Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3
...vegetables may be what you need say researchers. I...ioxidants in fruits and vegetables which may redu...ype of stroke caused when blood clots cut off oxyg...the antioxidants found in fruits and vegetables. F...
...regenerate following exercise or injury and harbor...plish the job: satellite cells and adult stem cell...cells. A certain group of these stem cells is invo...nto the muscle cell development pathway by injury....
...people will be diagnosed with kidney cancer. About...n earlier and more// accurate diagnosis. Mike Froz...ncer. Currently, the only way to detect kidney can...y scan or magnetic resonance imaging, but Frozzitt...
...ted States each year. On average, men who smoke sh.../ who smoke cut their life expectancy by about 15 ...king. In 1964, the Surgeon General’s Report showe...ung and larynx in men and chronic bronchitis in bo...
Other Medicine News:Health News:Regeneration of muscle 2Health News:Urine Test for Kidney Cancer 2
(Date:11/20/2008)...ewswire/ -- Milk. It does a body good. And,now it...fter years of,research, scientists at OncoNutriti...lk that stimulate the body,s own production of ant...s Release, go to:, http://www.prnewswire.com/mnr/e...ew cancer therapies, the chief scientist, Dr. Davi...
(Date:11/20/2008)...-- Clinical data from a prospective,registry pres... shows DVT,treatment with the Trellis(R) Peripher...anta Clara, CA) successfully breaks up the blood c... This technique, called isolated pharmacomechanic... and safely than current catheter-directed thrombo...
(Date:11/19/2008)... Amgen,(Nasdaq: AMGN )...bsidiary of,Takeda Pharmaceutical Company Limited...the Phase 3 MONET1 trial evaluating motesanib (AMG...tin for the first-line treatment of,advanced non-...y suspended,following a planned safety data revie...
(Date:11/19/2008)...re/ -- Isogen, a contract development and,manufac...ounced the first,phase launch of its contract fac...ally address the process, facility and capacity pr...ghly-niched, low-volume clinical and,early-stage ... Companies can invest over $100 million and four ...
Breaking Medicine Technology:Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Isogen Launches Major New Facility to Address Global Biopharma Demand 2BioMarin Announces First Quarter 2008 Financial Results 4955 1BioMarin Announces First Quarter 2008 Financial Results 4955 2BioMarin Announces First Quarter 2008 Financial Results 4955 3BioMarin Announces First Quarter 2008 Financial Results 4955 4BioMarin Announces First Quarter 2008 Financial Results 4955 5BioMarin Announces First Quarter 2008 Financial Results 4955 6BioMarin Announces First Quarter 2008 Financial Results 4955 7BioMarin Announces First Quarter 2008 Financial Results 4955 8BioMarin Announces First Quarter 2008 Financial Results 4955 9BioMarin Announces First Quarter 2008 Financial Results 4955 10BioMarin Announces First Quarter 2008 Financial Results 4955 11Nephros Appoints Gerald J Kochanski as Chief Financial Officer 4951 1Nephros Appoints Gerald J Kochanski as Chief Financial Officer 4951 2Nephros Appoints Gerald J Kochanski as Chief Financial Officer 4951 3Nephros Appoints Gerald J Kochanski as Chief Financial Officer 4951 4Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases 1932 1Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases 1932 2Engineers harness cell phone technology for use in medical imaging 4950 1Engineers harness cell phone technology for use in medical imaging 4950 2Engineers harness cell phone technology for use in medical imaging 4950 3Engineers harness cell phone technology for use in medical imaging 4950 4
...PHIS, Tenn.--(BUSINESS WIRE)--May 25, 2007 - GTx, ...m the recent Phase II proof of,concept clinical tr... clinical trial evaluating ACAPODENE(R) (toremifen...e effects of androgen,deprivation therapy (ADT) wi...g of the American Society of Clinical Oncology bei...
...NFORD, Calif.--(BUSINESS WIRE)--May 24, 2007 - A n...studies are designed in ways,that inadvertently om... The Stanford University School of Medicine,resear...emind all,scientists that strict study eligibility...es., In reviewing data from a pool of 100,000 alco...
Other Medicine Technology:GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 2GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 3Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 2Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 3
It provides excellent illumination from an inexpensive platform and is mounted on the comfortable UltraLite headband.
A rapid rise in intracranial pressure requires early recognition, intervention and continuous monitoring. Ventrix utilizes state-of-the-art fiberoptic technology that gets to the source of pressure.
The Codman ICP Monitoring System provides highly accurate measurements of intracranial pressure at the source-subdural, parenchymal or intraventricular levels. The information is relayed electronical
Slightly curved blunt dissector, double-ended. Length 11 1/2" (272 mm)
Medicine Products: